Abstract

Recent observations strongly connect high-density lipoproteins (HDL) function and levels with coronary heart disease outcomes and risk for infections and sepsis. To date, our knowledge of factors determining this connection is still very limited. The immobility associated with prolonged bedrest is detrimental to health, affecting several systems, including the cardiovascular, pulmonary, gastrointestinal, musculoskeletal and urinary. Effects of prolonged bedrest on the composition and functional properties of HDL remain elusive. We evaluated metrics of HDL composition and function in healthy male volunteers participating in a randomized, crossover head-down bedrest study. We observed that HDL cholesterol efflux capacity was profoundly decreased during bedrest, mediated by a bedrest associated reduction in plasma levels of HDL-cholesterol and major apolipoproteins (apo) apoA-I and apoA-II. Paraoxonase activity, plasma anti-oxidative capacity and the activities of lecithin-cholesterol acyltransferase and cholesteryl ester transfer protein were not affected. No change was observed in the content of HDL-associated serum amyloid A, a sensitive marker of inflammation. Resistive vibration exercise countermeasure during bedrest did not correct impaired cholesterol efflux capacity and only tended to increase arylesterase activity of HDL-associated paraoxonase. In conclusion, prolonged bedrest reduces plasma HDL levels linked to markedly suppressed HDL cholesterol efflux capacity. Resistive vibration exercise during bedrest did not correct HDL levels and impaired cholesterol efflux capacity.

Details

Title
Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity
Author
Trakaki Athina 1 ; Scharnagl Hubert 2 ; Trieb, Markus 3 ; Holzer, Michael 1 ; Hinghofer-Szalkay Helmut 4 ; Goswami Nandu 4 ; Marsche Gunther 3 

 Medical University of Graz, Division of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476) 
 Medical University of Graz, Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476) 
 Medical University of Graz, Division of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476); BioTechMed Graz, Graz, Austria (GRID:grid.452216.6) 
 Medical University of Graz, Division of Physiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1958616720
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.